Austco Healthcare Limited (ASX:AHC)
Australia · Delayed Price · Currency is AUD 0.3600
0.00 (0.00%)
Feb 11, 2026, 10:44 AM AEST
Austco Healthcare Revenue
In the fiscal year ending June 30, 2025, Austco Healthcare had annual revenue of 81.41M AUD with 39.98% growth. Austco Healthcare had revenue of 44.50M in the half year ending June 30, 2025, with 107.58% growth.
Revenue
81.41M
Revenue Growth
+39.98%
P/S Ratio
1.66
Revenue / Employee
798.09K
Employees
102
Market Cap
134.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 81.41M | 23.25M | 39.98% |
| Jun 30, 2024 | 58.15M | 16.18M | 38.53% |
| Jun 30, 2023 | 41.98M | 6.10M | 16.99% |
| Jun 30, 2022 | 35.88M | 4.63M | 14.82% |
| Jun 30, 2021 | 31.25M | -348.00K | -1.10% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Sigma Healthcare | 6.00B |
| Cochlear | 2.34B |
| Pro Medicus | 212.98M |
| SomnoMed | 111.49M |
| Vita Life Sciences | 85.60M |
| Alcidion Group | 40.79M |
| Actinogen Medical | 5.49M |